These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6479157)

  • 41. [Results of Tigason treatment of children with severe forms of psoriasis and ichthyosis].
    Rosińska D; Wolska H; Konca I
    Przegl Dermatol; 1987; 74(4-5):344-51. PubMed ID: 3329749
    [No Abstract]   [Full Text] [Related]  

  • 42. The effect of etretinate on plasma fibronectin in patients with vulgar psoriasis.
    Nishimura M; Nakayama J; Asahi M; Morito F
    J Dermatol; 1988 Apr; 15(2):191-3. PubMed ID: 3049737
    [No Abstract]   [Full Text] [Related]  

  • 43. Joint pains with psoriasis and long-term systemic etretinate therapy: a case report and summary of 12 cases.
    Ishida Y; Ozawa A; Ohkido M; Imai N
    J Dermatol; 1993 Oct; 20(10):651-3. PubMed ID: 8277044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Retinoid therapy and phototherapy of psoriasis (author's transl)].
    Schauder S
    Dermatologica; 1981; 162(4):236-42. PubMed ID: 7262380
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Etretinate approved.
    FDA Drug Bull; 1986 Nov; 16(2):16-7. PubMed ID: 3817343
    [No Abstract]   [Full Text] [Related]  

  • 46. Etretinate therapy reduces inpatient treatment of psoriasis.
    Ellis CN; Hermann RC; Gorsulowsky DC; Goldfarb MT; Voorhees JJ
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 1):787-91. PubMed ID: 3680657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Epidermic chalone receptors in psoriasis treated with retinoid:Ro 10-9359].
    Vignale RA; Lasalvia E; Espasandín J; Borras A
    Med Cutan Ibero Lat Am; 1983; 11(4):241-6. PubMed ID: 6314070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes.
    Ellis CN; Kang S; Grekin RC; LoBuglio AF; Voorhees JJ
    Arch Dermatol; 1985 Jul; 121(7):877-80. PubMed ID: 4015133
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Tigason in psoriasis. Advantage of progressively increasing doses].
    Dubertret L
    Ann Dermatol Venereol; 1985; 112(3):289-90. PubMed ID: 4062173
    [No Abstract]   [Full Text] [Related]  

  • 50. Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinate.
    Glazer SD; Roenigk HH; Yokoo H; Sparberg M; Paravicini U
    J Am Acad Dermatol; 1984 Apr; 10(4):632-8. PubMed ID: 6715613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use.
    Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM
    Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ro 10-9359, an aromatic retinoid in the treatment of psoriatic arthritis. Clinical and immunological studies.
    Rosenthal M
    Arzneimittelforschung; 1982; 32(8):842-4. PubMed ID: 6890362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Pustular psoriasis: the appearance of Lyell's syndrome and a lymphoblastic transformation test positive to Ro 10-9359].
    Oleffe J; de Bast C; Van Opdenbosch L; De Coninck A
    Dermatologica; 1982 Nov; 165(5):446-9. PubMed ID: 7169116
    [No Abstract]   [Full Text] [Related]  

  • 54. Peripheral neuropathy during etretinate therapy for psoriasis.
    Hammer CJ; Carter CC; Hanifin JM
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):272-3. PubMed ID: 8381828
    [No Abstract]   [Full Text] [Related]  

  • 55. Erythrocyte membrane phosphorylation in untreated and in etretinate-treated psoriatic patients.
    Kumar R; Weiss VC; West DP; Chiero LA
    Br J Dermatol; 1983 Sep; 109(3):277-86. PubMed ID: 6615715
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Phospholipid involvement in psoriatic epidermis.
    Ansidei V; Binazzi M; Cantelmi A; Gaiti A; Porcellati G
    Ital J Biochem; 1981; 30(1):40-5. PubMed ID: 7251339
    [No Abstract]   [Full Text] [Related]  

  • 57. The use of etretinate in psoriatic arthropathy.
    Woo J; Yip SY; Wang SW
    Postgrad Med J; 1985 Sep; 61(719):843. PubMed ID: 4059151
    [No Abstract]   [Full Text] [Related]  

  • 58. Etretinate. Appropriate use in severe psoriasis.
    Lowe NJ; Roenigk H; Voorhees JJ
    Arch Dermatol; 1988 Apr; 124(4):527-8. PubMed ID: 3281595
    [No Abstract]   [Full Text] [Related]  

  • 59. Etretinate (Tigason) for skin disease.
    Drug Ther Bull; 1983 Feb; 21(3):9-11. PubMed ID: 6839967
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment modalities of psoriatics over a 6-year period (1975-1981).
    Foged EK; Schmidt H
    Dermatologica; 1984; 168(2):90-3. PubMed ID: 6698270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.